BRIEF-Rosetta Genomics enters research collaboration using microrna biomarkers to predict response to leading immuno-oncology drug nivolumab in lung cancer patients
November 21, 2016 at 08:12 AM EST
* Rosetta genomics enters research collaboration using microrna biomarkers to predict response to leading immuno-oncology drug nivolumab in lung cancer patients Source text for Eikon: Further company coverage:
